Topic: Continuing the Conversation: Starting Treatment: Buprenorphine Induction 101

Save the Date: January 28, 2020, 12-1PM.

Featured Speaker: Candy Stockton, MD

Description: This one-hour Q & A session with Candy Stockton, MD is a follow up to the January 14th webinar on buprenorphine starts in various treatment settings. It will offer an opportunity to "continue the conversation" with Dr. Stockton and ask specific questions about best practices on starting buprenorphine treatment for opioid use disorder. Attendance at the first event is not required.

Continuing Medical Education and Continuing Education (CME/CE) credit offered at no cost!

Note: Registering here will allow you to attend any of our future sessions. You can cancel your registration at any time.

For more information, contact Cfrable@mednet.ucla.edu

The MAT Waivered Prescriber Support initiative is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) State Opioid Response Grant to the California Department of Health Care Services (DHCS).